See more : The Liberty SiriusXM Group (LSXMA) Income Statement Analysis – Financial Results
Complete financial analysis of iAnthus Capital Holdings, Inc. (ITHUF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of iAnthus Capital Holdings, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- NOK Corporation (7240.T) Income Statement Analysis – Financial Results
- Zuger Kantonalbank (ZUGER.SW) Income Statement Analysis – Financial Results
- Magna Gold Corp. (MGR.V) Income Statement Analysis – Financial Results
- UserTesting, Inc. (USER) Income Statement Analysis – Financial Results
- CleanGo Innovations Inc. (CGII.CN) Income Statement Analysis – Financial Results
iAnthus Capital Holdings, Inc. (ITHUF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.ianthus.com
About iAnthus Capital Holdings, Inc.
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 32 dispensaries and 10 cultivation and/or processing facilities in 8 states. The company was founded in 2014 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 159.24M | 163.21M | 203.02M | 151.67M | 78.38M | 3.41M | 2.41M | 391.65K | 45.57K | 0.00 |
| Cost of Revenue | 96.07M | 88.78M | 91.74M | 64.99M | 38.52M | 6.19M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 63.17M | 74.43M | 111.28M | 86.68M | 39.87M | -2.78M | 2.41M | 391.65K | 45.57K | 0.00 |
| Gross Profit Ratio | 39.67% | 45.60% | 54.81% | 57.15% | 50.86% | -81.69% | 100.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 73.17M | 107.59M | 90.32M | 0.00 | 90.82M | 35.52M | 9.81M | 4.02M | 1.36M | 998.17K |
| Selling & Marketing | 4.35M | 4.80M | 4.54M | 0.00 | 5.14M | 0.00 | 0.00 | 0.00 | 0.00 | 5.12K |
| SG&A | 78.01M | 112.39M | 96.97M | 109.04M | 90.82M | 35.52M | 9.81M | 4.02M | 1.36M | 1.56M |
| Other Expenses | 25.87M | 32.26M | 30.52M | 29.30M | 23.63M | 6.35M | -17.63K | -200.81K | 0.00 | 0.00 |
| Operating Expenses | 103.88M | 144.65M | 127.48M | 138.33M | 114.45M | 41.87M | 9.96M | 4.03M | 1.36M | 1.56M |
| Cost & Expenses | 199.15M | 233.43M | 219.22M | 203.32M | 152.97M | 35.69M | 9.96M | 4.03M | 1.36M | 1.56M |
| Interest Income | 1.85M | 86.00K | 517.00K | 403.00K | 75.72K | 566.87K | 1.98M | 306.47K | 21.22K | 0.00 |
| Interest Expense | 30.16M | 22.25M | 32.67M | 37.65M | 25.25M | 20.93M | 2.49M | 290.82K | 0.00 | 0.00 |
| Depreciation & Amortization | 27.17M | 30.15M | 30.77M | 29.39M | 23.01M | 6.03M | 149.37K | 7.65K | 1.32M | 1.56M |
| EBITDA | -13.30M | -369.80M | 7.89M | -241.27M | -273.12M | -32.97M | -11.48M | -4.70M | 0.00 | -1.06K |
| EBITDA Ratio | -8.35% | -15.33% | 8.34% | -14.84% | -64.90% | -742.86% | -316.51% | -1,149.35% | -2,887.57% | 0.00% |
| Operating Income | -40.71M | -70.22M | -14.11M | -51.65M | -74.50M | -31.65M | -7.55M | -3.64M | -1.32M | -1.56M |
| Operating Income Ratio | -25.57% | -43.02% | -6.95% | -34.06% | -95.05% | -929.31% | -313.62% | -928.56% | -2,887.57% | 0.00% |
| Total Other Income/Expenses | -19.21M | -326.25M | -31.48M | -49.68M | 12.59M | -21.28M | -4.04M | -1.42M | 0.00 | -1.06K |
| Income Before Tax | -59.92M | -438.70M | -54.00M | -290.07M | -304.28M | -62.03M | -13.72M | -5.06M | -1.32M | -1.56M |
| Income Before Tax Ratio | -37.63% | -268.79% | -26.60% | -191.25% | -388.20% | -1,821.51% | -569.81% | -1,290.87% | -2,887.57% | 0.00% |
| Income Tax Expense | 16.70M | 10.69M | 22.25M | 19.96M | -3.03M | 9.45M | 2.27M | 326.94K | -1.32M | -1.06K |
| Net Income | -76.62M | -449.39M | -76.25M | -310.03M | -301.25M | -71.48M | -13.72M | -5.06M | -1.32M | -1.56M |
| Net Income Ratio | -48.12% | -275.34% | -37.56% | -204.41% | -384.34% | -2,098.96% | -569.81% | -1,290.87% | -2,887.57% | 0.00% |
| EPS | -0.01 | -0.07 | -0.44 | -1.81 | -1.90 | -1.12 | -0.48 | -0.32 | -0.08 | -0.16 |
| EPS Diluted | -0.01 | -0.07 | -0.44 | -1.81 | -1.90 | -1.12 | -0.48 | -0.32 | -0.08 | -0.16 |
| Weighted Avg Shares Out | 6.44B | 6.40B | 171.72M | 171.65M | 158.21M | 63.86M | 28.58M | 15.80M | 16.95M | 9.78M |
| Weighted Avg Shares Out (Dil) | 6.44B | 6.40B | 171.72M | 171.65M | 158.21M | 63.86M | 28.61M | 15.98M | 16.95M | 10.00M |
iAnthus Provides Update on Executive Team
NEW YORK and TORONTO , Oct. 12, 2023 /PRNewswire/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, announces that Robert Galvin will transition...
iAnthus Announces Third Medical Cannabis Dispensary and Grand Opening of New Jersey Adult Use Dispensary
NEW YORK and TORONTO , Sept. 26, 2023 /PRNewswire/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), a leading national cannabis consumer packaged goods company and owner of MPX-NJ dispensaries, is pleased to announce the...
iAnthus Reports Second Quarter 2023 Financial Results
NEW YORK and TORONTO , Aug. 14, 2023 /PRNewswire/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results...
iAnthus Announces Appointment of Richard Proud as CEO and Director
NEW YORK and TORONTO , July 17, 2023 /PRNewswire/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, is pleased to announce the...
Where Is The Value In Cannabis Stocks?
Bengal Capital's Jerry Derevyanny moved away from top multi-state operators (MSOs) to find the most value. Why EBITDA falls short as a useful metric to measure cannabis stocks.
iAnthus Closes Acquisition Of New Jersey License Holder
iAnthus Capital Holdings, Inc. IAN ITHUF announced the closing of its acquisition of 100% of the equity interests of MPX New Jersey, LLC, a medical cannabis permit holder in New Jersey. What Happened?
Alan Brochstein On Cannabis Investing In 2022 (Video Transcript)
Alan Brochstein On Cannabis Investing In 2022 (Video Transcript)
iAnthus Reports 21% YoY Revenue Increase And Net Loss Decline In Q3 Despite 2020 Challenges
Cannabis operator iAnthus Capital Holdings, Inc. (CSE:IAN) (OTCPK: ITHUF) reported its financial results Monday for the three and nine months ended Sept. 30, revealing a 21% year-over-year increase in revenue, which totaled $49.3 million in the third quarter of fiscal 2021.
iAnthus Capital Cannabis Co. Shares Up Slightly After Revealing 57% Surge In Q2 2021 Revenue Following A Tough Year
Cannabis company iAnthus Capital Holdings, Inc. (CSE:IAN) (OTCPK: ITHUF) reported its financial results on Tuesday for the three and six months ended June 30, revealing a 57% surge in revenue for the second quarter of 2021, reaching $54.2 million. Gross profit...
The Cheapest And Most Expensive Cannabis Stocks
Billions of dollars flooded into the cannabis sector in a tsunami-like fashion following the democrats assuming control of the United States senate following Georgia's runoff election.
Source: https://incomestatements.info
Category: Stock Reports